×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMMX – immix biopharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMMX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/9
08:45 am
immx
Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
High
Report
Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
3/30
10:20 am
immx
Immix Biopharma (IMMX) had its price target raised by Mizuho from $14.00 to $15.00. They now have an "outperform" rating on the stock.
Medium
Report
Immix Biopharma (IMMX) had its price target raised by Mizuho from $14.00 to $15.00. They now have an "outperform" rating on the stock.
3/30
08:45 am
immx
Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
Low
Report
Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
3/27
09:53 am
immx
Immix Biopharma (IMMX) had its "market outperform" rating reaffirmed by Citizens Jmp. They now have a $23.00 price target on the stock.
Medium
Report
Immix Biopharma (IMMX) had its "market outperform" rating reaffirmed by Citizens Jmp. They now have a $23.00 price target on the stock.
3/27
08:02 am
immx
Immix Biopharma (IMMX) had its price target raised by HC Wainwright from $12.00 to $15.00. They now have a "buy" rating on the stock.
Medium
Report
Immix Biopharma (IMMX) had its price target raised by HC Wainwright from $12.00 to $15.00. They now have a "buy" rating on the stock.
3/25
08:42 am
immx
Immix Biopharma (IMMX) is now covered by Morgan Stanley. They set an "overweight" rating and a $20.00 price target on the stock.
Low
Report
Immix Biopharma (IMMX) is now covered by Morgan Stanley. They set an "overweight" rating and a $20.00 price target on the stock.
3/15
01:05 am
immx
Immix Biopharma (IMMX) was downgraded by Wall Street Zen from "hold"
Medium
Report
Immix Biopharma (IMMX) was downgraded by Wall Street Zen from "hold"
3/9
08:03 am
immx
Immix Biopharma (IMMX) is now covered by Citizens Jmp. They set a "market outperform" rating and a $23.00 price target on the stock.
High
Report
Immix Biopharma (IMMX) is now covered by Citizens Jmp. They set a "market outperform" rating and a $23.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/6
04:42 pm
immx
Form ARS Immix Biopharma, Inc. For: Dec 31
Medium
Report
Form ARS Immix Biopharma, Inc. For: Dec 31
4/6
04:39 pm
immx
Form DEFA14A Immix Biopharma, Inc.
Medium
Report
Form DEFA14A Immix Biopharma, Inc.
4/6
04:38 pm
immx
Form DEF 14A Immix Biopharma, Inc. For: Apr 06
Medium
Report
Form DEF 14A Immix Biopharma, Inc. For: Apr 06
3/30
05:43 pm
immx
Form 8-K Immix Biopharma, Inc. For: Mar 30
Medium
Report
Form 8-K Immix Biopharma, Inc. For: Mar 30
3/27
05:29 pm
immx
Form 10-K/A Immix Biopharma, Inc. For: Dec 31
Medium
Report
Form 10-K/A Immix Biopharma, Inc. For: Dec 31
3/25
05:24 pm
immx
Form 8-K Immix Biopharma, Inc. For: Mar 25
Low
Report
Form 8-K Immix Biopharma, Inc. For: Mar 25
3/25
05:22 pm
immx
Form 424B5 Immix Biopharma, Inc.
Low
Report
Form 424B5 Immix Biopharma, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: